CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 30 enrolled
Drug / intervention
L-Glutamine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00296621
NCT00296621Phase 2Completed
CompareCT.gov

Efficacy Study of Oral Glutamine Supplementation in Duchenne Muscular Dystrophy

Assistance Publique - Hôpitaux de Paris·interventional·Posted Feb 27, 2006·Updated Dec 21, 2007

In Brief

A Phase 2 clinical trial evaluating L-Glutamine and placebo for Muscular Dystrophy, Duchenne. Completed, enrolled 30 participants across 5 sites.

Detailed Summary

The purpose of this study is to determine whether long-term oral glutamine supplementation is effective in improving muscle mass and function in children with Duchenne muscular dystrophy (DMD).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMuscular Dystrophy, Duchenne
CountriesFrance
Collaborators--

Timeline

Phase 2CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 27, 2006
Enrollment StartFeb 1, 2006
Primary CompletionFeb 1, 2008
Study CompletionNov 1, 2007
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 20.3 years ago

Interventions

L-Glutaminedrug

L-Glutamine

placebodrug

placebo